首页> 美国卫生研究院文献>Euroasian Journal of Hepato-Gastroenterology >Drug-induced Liver Disease in Patients with Diabetes Mellitus
【2h】

Drug-induced Liver Disease in Patients with Diabetes Mellitus

机译:糖尿病患者的药物性肝病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The study presented here was accomplished to assess the course of drug-induced liver diseases in patient’s rheumatoid arthritis receiving long-term methotrexate therapy. Diabetes mellitus was revealed as the most significant risk factor. The combination of diabetes mellitus with other risk factors (female sex) resulted in increased hepatic fibrosis, degree of hepatic encephalopathy and reduction of hepatic functions. The effectiveness and safety of ursodeoxycholic acid and cytolytic type-with S-Adenosyl methionine was also evaluated.Abbreviations13C-MBT: 13C-methacetin breath test; ALT: alanine aminotransferase; AP: alkaline phosphatase; AST: aspartic transaminase; DILD: drug-induced liver disease; DM: diabetes mellitus; HE: hepatic encephalopathy; HFM: hepatic functional mass; SAMe: S-Adenosyl methionine; UDCA: ursodeoxycholic acid.
机译:此处进行的研究旨在评估接受长期氨甲蝶呤治疗的类风湿关节炎患者药物性肝病的病程。糖尿病被认为是最重要的危险因素。糖尿病与其他危险因素(女性)的结合导致肝纤维化增加,肝性脑病程度和肝功能降低。还评估了熊去氧胆酸和溶细胞型S-腺苷甲硫氨酸的有效性和安全性。缩写13C-MBT:13C-美沙西丁呼气试验; ALT:丙氨酸转氨酶; AP:碱性磷酸酶; AST:天冬氨酸转氨酶; DILD:药物性肝病; DM:糖尿病; HE:肝性脑病; HFM:肝功能量; SAMe:S-腺苷甲硫氨酸; UDCA:熊去氧胆酸。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号